Welcome to The Lab — start here
Welcome to The Lab — the research community behind The Vial Theory. 🧪 This is a space for evidence first discussion of peptide science. A few quick orientations: Theories are post…
Loading
Loading
The Vial Theory community is for educational and research discussion only. User content is not medical advice. Always consult a licensed healthcare professional before making health-related decisions.
@corith · Joined June 2026
Founder · The Vial Theory. Evidence-first peptide research.
Welcome to The Lab — the research community behind The Vial Theory. 🧪 This is a space for evidence first discussion of peptide science. A few quick orientations: Theories are post…
Welcome to The Lab — the research community behind The Vial Theory. 🧪 This is a space for evidence first discussion of peptide science. A few quick orientations: Theories are post…
Two different strategies are worth keeping straight when you compare the metabolic peptides: Single multi receptor molecule — one engineered peptide hits several receptors. Tirzepa…
Personal reports are welcome here — they can surface questions worth studying. A few norms to keep them useful and compliant: Share observations and context , not protocols. No dos…
The single most useful filter in peptide research is regulatory status. These are not interchangeable: Approved — cleared for a specific use after large trials (e.g. semaglutide, t…
Paper: Enebo et al., The Lancet (2021) — a Phase 1b/2a trial of cagrilintide co administered with semaglutide in adults with overweight or obesity. What it tested: tolerability and…
Not every alarming anecdote is a safety signal — and "well tolerated" doesn't mean safe. How to tell the difference: Case reports (e.g. regulator warnings around the unapproved "ta…
New Research Brief is up: CagriSema and the Two Hormone Bet. The short version: CagriSema pairs cagrilintide (a long acting amylin analog) with semaglutide (a GLP 1) in one weekly…
Why pair two appetite hormones instead of pushing one harder? Because they don't fully overlap: GLP 1 (e.g. semaglutide) slows gastric emptying and acts on central satiety circuits…
Intro thread — tell us: What first got you reading about peptides? One compound whose evidence surprised you (in either direction). What you're hoping to learn here. I'll start: th…
Here's a clean one to argue with evidence, not vibes. Claim: adding an amylin analog (cagrilintide) on top of a GLP 1 (semaglutide) produces meaningfully more benefit than the GLP…
A vendor neutral primer on what testing numbers actually mean (concepts only — this isn't sourcing advice): HPLC purity (%) estimates how much of a sample is the target peptide vs.…
If you're just getting into peptides, these three questions filter out most of the hype: 1. Is it human evidence? A result in mice is a hypothesis, not proof. Compounds with only a…